Image Source: CNBC
Nasdaq shares and technology stocks pushed the broader market higher Tuesday, with the tech-heavy index reaching a fresh all-time intraday high as investors weighed artificial intelligence optimism against rising geopolitical uncertainty.
The Nasdaq Composite was last up about 0.4%, building on Monday’s strong rally and briefly reaching 27,250.92. The move marked its first intraday record since June 1, 2026, following the index’s first record close since June 2 during the previous session.
The S&P 500 was little changed, while the Dow Jones Industrial Average fell 213 points, or 0.4%. The mixed performance showed how heavily the latest advance depended on large technology and artificial intelligence-related companies.
Nasdaq Reaches a Fresh Record as AI Stocks Lead
Several technology and semiconductor names helped support the Nasdaq’s advance. Sandisk shares climbed about 4% after Rosenblatt initiated coverage with a buy rating and issued a $2,400 price target. The target implied roughly 36% upside from Monday’s closing price.
According to Rosenblatt analyst Kevin Cassidy, new AI computing platforms could reposition NAND flash memory from a commodity storage product into a more important part of artificial intelligence infrastructure. Sandisk shares have already gained sharply in 2026, making the bullish call a significant development for technology investors.
Alibaba also added to the AI momentum. Its shares rose around 3% in Hong Kong after the Chinese technology company introduced the Zhenwu V900 artificial intelligence chip. Alibaba said the new chip delivers three times the performance of its predecessor, the Zhenwu M890.
The company also outlined plans to expand Alibaba Cloud’s global data center capacity to more than 20 gigawatts by 2032. The announcement reinforced investor interest in the growing demand for computing power, cloud infrastructure and AI models.
Powerful Biotech Rally Adds to Market Action
Beyond technology, healthcare stocks attracted strong attention. Viking Therapeutics shares surged about 31% after the company announced positive results from a maintenance study of its experimental obesity and diabetes treatment, VK2735.
Patients taking the once-weekly injection lost between 16% and 19% of their body weight after 21 weeks. The results put Viking in closer competition with Eli Lilly and Novo Nordisk, which currently dominate the obesity-drug market with treatments such as Zepbound and Mounjaro.
Roche also reported progress with its experimental weight-loss medicine, enicepatide. Patients with Type 2 diabetes lost 15.5% of their body weight over 48 weeks, while their blood sugar levels also improved significantly.
Oil Prices and Iran Tensions Keep Traders Alert
Despite the Nasdaq’s strength, investors remained focused on the potential impact of the conflict between the United States and Iran. President Donald Trump told the United Nations General Assembly that he faced a major decision on whether to pursue an agreement with Iran or “annihilate” the country.
Oil prices pared earlier losses after the remarks. Brent crude futures were down less than 1% near $100 per barrel, while U.S. crude traded around $95. Oil was on track for a fifth consecutive daily decline.
Prices had fallen earlier after reports that Iran offered to reopen the Strait of Hormuz within seven days if the United States took steps toward de-escalation. CNBC said the report had not been independently verified. Saudi Arabia was also reportedly preparing to restart its East-West pipeline.
Lower oil prices helped fuel Monday’s rally because they eased fears about inflation and corporate costs. Treasury yields also declined, offering additional support to growth-oriented technology shares. However, renewed tensions could quickly reverse that trend.
Trump-Xi Meeting Becomes a Critical Market Test
Investors are now looking ahead to a summit in Washington between Trump and Chinese leader Xi Jinping. Artificial intelligence, tariffs, rare earth metals and the Iran war are expected to feature prominently in the discussions.
The upcoming meeting could influence market sentiment well beyond Tuesday. Any progress on trade relations may benefit multinational companies and technology stocks, while renewed tension could pressure equities, bonds and industrial sectors.
Market breadth also remains a concern. CNBC reported that more S&P 500 stocks reached new 52-week lows than new highs during Monday’s rally, despite the index finishing near its record level. That unusual divergence has prompted some investors to question how durable the advance may be.
What the Nasdaq Rally Means for Investors
- AI leadership: Semiconductor, cloud and data-center stocks remain central to market gains.
- Geopolitical risk: Iran-related developments could affect oil prices and inflation expectations.
- Market breadth: A narrow rally may signal that fewer companies are driving the index higher.
- Policy focus: The Trump-Xi meeting could shape expectations for tariffs and global trade.
For now, the Nasdaq remains supported by enthusiasm over artificial intelligence and strong momentum in large technology companies. Still, elevated oil prices, geopolitical uncertainty and uneven participation across the market mean investors are likely to remain cautious as the week continues.
FAQs About the Nasdaq
Why did the Nasdaq reach a fresh record?
The Nasdaq rose as technology and artificial intelligence stocks gained. Sandisk, Alibaba and other AI-linked companies helped lift the index.
What was the Nasdaq’s gain Tuesday?
The Nasdaq Composite was last up about 0.4% and reached an intraday high of 27,250.92.
How are Iran tensions affecting the stock market?
Investors are watching whether the conflict pushes oil prices higher. More expensive crude could increase inflation and pressure corporate profits.
Why is the Trump-Xi meeting important?
The leaders are expected to discuss tariffs, artificial intelligence, rare earth metals and trade relations, all of which could influence global markets.
